These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


322 related items for PubMed ID: 10130385

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of two systems for documenting pharmacist interventions in patient care.
    Schumock GT, Hutchinson RA, Bilek BA.
    Am J Hosp Pharm; 1992 Sep; 49(9):2211-4. PubMed ID: 1524064
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ, Smith SR.
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Overestimating clinical functions of distributive staff pharmacists.
    Dillon KR, Caselnova DA.
    Hosp Pharm; 1989 Oct; 24(10):849-52. PubMed ID: 10295901
    [Abstract] [Full Text] [Related]

  • 28. Documentation of pharmacist interventions in a decentralized unit dose system.
    Hoolihan RJ, Skoogman LH.
    Hosp Pharm; 1991 Oct; 26(10):875-9. PubMed ID: 10114008
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Six Sigma: not for the faint of heart.
    Benedetto AR.
    Radiol Manage; 2003 Oct; 25(2):40-53. PubMed ID: 12800564
    [Abstract] [Full Text] [Related]

  • 32. Quality assurance program for a nuclear pharmacy.
    Hiltz A, Pierce S.
    Can J Hosp Pharm; 1991 Feb; 44(1):25-9. PubMed ID: 10110040
    [Abstract] [Full Text] [Related]

  • 33. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR, Bellanger-McCleery RA, Fuchs JE.
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [Abstract] [Full Text] [Related]

  • 34. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W.
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [Abstract] [Full Text] [Related]

  • 35. Clinical career ladders: the Washington Hospital Center.
    Barbaccia JG, Mowrey D.
    Am J Hosp Pharm; 1989 Nov; 46(11):2276-9. PubMed ID: 2589342
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Quality assurance and certification program for an aminoglycoside monitoring service.
    Shevchuk YM, Poulin S.
    Can J Hosp Pharm; 1990 Apr; 43(2):49-55. PubMed ID: 10106632
    [Abstract] [Full Text] [Related]

  • 38. Development of competency standards for quality assurance in clinical pharmacokinetics.
    Burkle WS, Matzke GR, Lucarotti RL.
    Hosp Pharm; 1980 Oct; 15(10):494-6. PubMed ID: 10249052
    [Abstract] [Full Text] [Related]

  • 39. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH, Sterba KJ, Szymusiak-Mutnick BA.
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [Abstract] [Full Text] [Related]

  • 40. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA.
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.